+1-518-621-2074 | US-Canada Toll Free Contact Us

Increased Regulatory Approvals Drive the Global Contrast Medium Injector Market

about us

Published on : Mar 18, 2020

The global contrast medium injector market is likely to witness substantial growth over the tenure of assessment. Increasing demand for minimally invasive surgeries together with the relentless advancement in the technology applied in this field is likely to influence growth of the global contrast medium injector market in the years to come. In addition, a rise in the number of regulatory approvals is also expected to help the market prosper over the period of assessment.

There have been numerous advancements made in the contrast medium injector technology to reduce the waste of contrast medium and to facilitate automated data collection pertaining to the dosage of a patient. For example, an automated injector systems accurately gathers the amount of contrast medium utilized and the market players have started offering customized doses for the patients. Such a measure has been made possible through utilization of the patient information pulled from picture archiving and communication system (PACS) or electronic medical record (EMR). Syringeless injectors are instances of one such advancement in diminishing contrast medium. 

Request a Sample PDF copy with detailed Insights: https://www.researchmoz.us/enquiry.php?type=S&repid=1893323

Sino Medical-Device Technology Co. Ltd, Bayer HealthCare LLC, Ulrich GmbH & Co. KG, Sino Medical-Device Technology Co., Ltd., Shenzen Seacrown Electromechanical Co Ltd., and Guerbet Group are some of the well-known players in the global contrast medium injector market.
Driven by Presence of Advanced Healthcare Facilities, Europe and North America to Witness Growth

Considering regional segmentation of the global contrast medium injector market, North America is estimated to dominate the market. Presence of highly advanced healthcare facilities in the region is expected to drive the contrast medium injector market in North America. In addition, accessibility to expert surgeons and radiologists in North America has triggered growth of the market in the region. Europe, too, accounted for a sizeable chunk of the market in terms of revenue owing to the presence of several leading companies in the region. Ulrich GmbH & Co. KG, Guerbet Group, Medtron AG, Bracco Group and Bayer HealthCare LLC have strong presence in the region. 

In addition to that, availability of high-end IT-enabled solutions for management of data available for multi-purpose analysis is likely to emerge as another growth factor for the contrast medium injector market in Europe and North America. This data is analyzed for purposes like ensuring safety of patients, workflow efficiencies, and imaging optimization. A case in point could be Radimetrics Enterprise Platform by Bayer HealthCare LLC and it can be incorporated with Medrad MRXperion MR Injection System.

Asia Pacific region is likely to emerge as rapidly growing region in the global contrast medium injector market, thanks to the developing healthcare infrastructure in many of the Asian countries such as Indonesia, India, and China. Increased prevalence of various chronic diseases like Alzheimer's, epilepsy, orthopedic diseases, and cancer is expected to encourage growth of the contrast medium injector market in the region.

Demand for Minimally Invasive Surgeries Stokes its Demand in the Market

Technological advancements made in the segment of contrast media injectors, comprising IT-enabled solutions for automated, dual-head, and syringeless injectors have led to incremental changes in the segment of medical imaging. Syringeless injectors are known to minimize wastage of contrast agent, considered more efficient and user friendly as compared to the other existing options. 

The global contrast medium injector market is forecasted to be driven by rising demand for minimally invasive surgical procedures. These surgical procedures offer many benefits such as shorter stay at hospitals, smaller incisions, minor surgical wounds, less pain, and quicker healing.  These benefits have stoked the demand for minimally invasive surgical procedures. With increased demand for these procedures, the global contrast medium injector market is likely to witness considerable growth in the years to come.

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.


get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074